Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mary Crowley Cancer Research is a non-profit clinical research center based in Dallas, Texas, specializing in early-phase oncology clinical trials. Since its founding in 1992, the clinic has focused on providing cancer patients access to innovative investigational therapies, including gene therapies, immunotherapies, and targeted molecular treatments. It functions as an independent clinical trial site, collaborating with global pharmaceutical and biotechnology companies to conduct Phase 1 and Phase 2 studies. The organization is recognized for its rapid trial activation and its contribution to the development of numerous FDA-approved cancer drugs. By integrating molecular profiling and personalized medicine, the clinic aims to align patients with the most promising clinical trials for their specific cancer types.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mary Crowley Medical Research Clinic.